The complexity of intestinal permeability: Assigning the correct BCS classification through careful data interpretation

European Journal of Pharmaceutical Sciences

Volumn 61, Issue 1, 2014, Pages 11-17

  Zur, Moran ^a   Hanson, Allison S ^a   Dahan, Arik ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

BCS classification; Biowaiver; Drug solubility; Intestinal absorption; Segmental dependent permeability

Indexed keywords

CODEINE PHOSPHATE; METOPROLOL TARTRATE; CODEINE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG ABSORPTION; DRUG CLASSIFICATION; DRUG PENETRATION; DRUG SOLUBILITY; ILEUM; IN VITRO STUDY; IN VIVO STUDY; INTESTINE MUCOSA PERMEABILITY; INTESTINE PERFUSION; JEJUNUM; NONHUMAN; PH; PRIORITY JOURNAL; RAT; SMALL INTESTINE; SMALL INTESTINE ABSORPTION; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; ABSORPTION; ANIMAL; CHEMISTRY; CLASSIFICATION; HUMAN; INTESTINE; INTESTINE ABSORPTION; MALE; METABOLISM; PERMEABILITY; PHARMACEUTICS; SOLUBILITY; WISTAR RAT;

ABSORPTION, PHYSICOCHEMICAL; ANIMALS; BIOPHARMACEUTICS; CODEINE; HUMANS; INTESTINAL ABSORPTION; INTESTINES; MALE; PERMEABILITY; RATS; RATS, WISTAR; SOLUBILITY;

EID: 84901210403     PISSN: 09280987     EISSN: 18790720     Source Type: Journal    
DOI: 10.1016/j.ejps.2013.11.007     Document Type: Article

References (58)

1. G.L. Amidon, H. Lennernas, V.P. Shah, and J.R. Crison A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability Pharmaceutical Research 12 1995 413 420
2. K.S. Amidon, P. Langguth, H. Lennernas, L. Yu, and G.L. Amidon Bioequivalence of oral products and the biopharmaceutics classification system: science, regulation, and public policy Clinical Pharmacology and Therapeutics 90 2011 467 470
3. A. Beig, J.M. Miller, and A. Dahan Accounting for the solubility-permeability interplay in oral formulation development for poor water solubility drugs: The effect of PEG-400 on carbamazepine absorption European Journal of Pharmaceutics and Biopharmaceutics 81 2012 386 391
4. L. Benet, G.L. Amidon, D. Barends, H. Lennernäs, J. Polli, V. Shah, S. Stavchansky, and L.X. Yu The use of BDDCS in classifying the permeability of marketed drugs Pharmaceutical Research 25 2008 483 488
5. L. Benet, F. Broccatelli, and T. Oprea BDDCS applied to over 900 drugs The AAPS Journal 13 2011 519 547
6. M. Bergstrand, E. Söderlind, U. Eriksson, W. Weitschies, and M. Karlsson A Semi-mechanistic modeling strategy for characterization of regional absorption properties and prospective prediction of plasma concentrations following administration of new modified release formulations Pharmaceutical Research 29 2012 574 584
7. E. Bodd, K.M. Beylich, A.S. Christophersen, and J. Mørland Oral administration of codeine in the presence of ethanol: a pharmacokinetic study in man Pharmacology and Toxicology 61 1987 297 300 (Pubitemid 18001857)
8. F. Broccatelli, G. Cruciani, L.Z. Benet, and T.I. Oprea BDDCS class prediction for new molecular entities Molecular Pharmaceutics 9 2012 570 580
9. X. Cao, L.X. Yu, C. Barbaciru, C.P. Landowski, H.-C. Shin, S. Gibbs, H.A. Miller, G.L. Amidon, and D. Sun Permeability dominates in vivo Intestinal absorption of P-gp substrate with high solubility and high permeability Molecular Pharmaceutics 2 2005 329 340 (Pubitemid 41186409)
10. CDER/FDA, 2000. Guidance for industry: Waiver of in vivo bioavailability and bioequivalence studies for immediate release dosage forms based on a biopharmaceutical slassification system. Center for Drug Evaluation and Research.
11. J.M. Custodio, C.-Y. Wu, and L.Z. Benet Predicting drug disposition, absorption/elimination/transporter interplay and the role of food on drug absorption Advanced Drug Delivery Reviews 60 2008 717 733
12. A. Dahan, and G. Amidon Grapefruit juice and its constituents augment colchicine intestinal absorption: potential hazardous interaction and the role of P-gp Pharmaceutical Research 26 2009 883 892
13. A. Dahan, and G.L. Amidon Segmental dependent transport of low permeability compounds along the small intestine due to P-gp: the role of efflux transport in the oral absorption of BCS class III drugs Molecular Pharmaceutics 6 2009 19 28
14. A. Dahan, and G.L. Amidon Small intestinal efflux mediated by MRP2 and BCRP shifts sulfasalazine intestinal permeability from high to low, enabling its colonic targeting American Journal of Physiology - Gastrointestinal and Liver Physiology 297 2009 G371 G377
15. A. Dahan, and G.L. Amidon MRP2 mediated drug-drug interaction: Indomethacin increases sulfasalazine absorption in the small intestine, potentially decreasing its colonic targeting International Journal of Pharmaceutics 386 2010 216 220
16. A. Dahan, and J. Miller The solubility-permeability interplay and its implications in formulation design and development for poorly soluble drugs The AAPS Journal 14 2012 244 251
17. A. Dahan, J. Miller, and G.L. Amidon Prediction of solubility and permeability class membership: provisional BCS classification of the world's top oral drugs The AAPS Journal 11 2009 740 746
18. A. Dahan, H. Sabit, and G.L. Amidon Multiple efflux pumps are involved in the transepithelial transport of colchicine: combined effect of P-gp and MRP2 leads to decreased intestinal absorption throughout the entire small intestine Drug Metabolism and Disposition 37 2009 2028 2036
19. A. Dahan, B.T. West, and G.L. Amidon Segmental-dependent membrane permeability along the intestine following oral drug administration: evaluation of a triple single-pass intestinal perfusion (TSPIP) approach in the rat European Journal of Pharmaceutical Sciences 36 2009 320 329
20. A. Dahan, J.M. Miller, J.M. Hilfinger, S. Yamashita, L.X. Yu, H. Lennernäs, and G.L. Amidon High-permeability criterion for BCS classification: segmental/pH dependent permeability considerations Molecular Pharmaceutics 7 2010 1827 1834
21. A. Dahan, J.M. Miller, A. Hoffman, G.E. Amidon, and G.L. Amidon The solubility-permeability interplay in using cyclodextrins as pharmaceutical solubilizers: mechanistic modeling and application to progesterone Journal of Pharmaceutical Sciences 99 2010 2739 2749
22. A. Dahan, H. Lennernäs, and G.L. Amidon The fraction dose absorbed, in humans, and high jejunal human permeability relationship Molecular Pharmaceutics 9 2012 1847 1851
23. L. Di, P. Artursson, A. Avdeef, G.F. Ecker, B. Faller, H. Fischer, J.B. Houston, M. Kansy, E.H. Kerns, S.D. Krämer, H. Lennernäs, and K. Sugano Evidence-based approach to assess passive diffusion and carrier-mediated drug transport Drug Discovery Today 17 2012 905 912
24. M. Fairstein, R. Swissa, and A. Dahan Regional-dependent intestinal permeability and BCS classification: elucidation of pH-related complexity in rats using pseudoephedrine The AAPS Journal 15 2013 589 597
25. a determination by capillary electrophoresis Electrophoresis 29 2008 2841 2851 (Pubitemid 352006117)
26. K. Giacomini, S. Huang, D. Tweedie, L. Benet, K. Brouwer, X. Chu, A. Dahlin, R. Evers, V. Fischer, K. Hillgren, K. Hoffmaster, T. Ishikawa, D. Keppler, R. Kim, C. Lee, M. Niemi, J. Polli, Y. Sugiyama, P. Swaan, J. Ware, S. Wright, S. Yee, M. Zamek-Gliszczynski, and L. Zhang Membrane transporters in drug development Nature Reviews Drug Discovery 9 2010 215 236
27. Y. Henchoz, D. Guillarme, S. Martel, S. Rudaz, J.-L. Veuthey, and P.-A. Carrupt Fast Log P determination by ultra-high-pressure liquid chromatography coupled with UV and mass spectrometry detections Analytical and Bioanalytical Chemistry 394 2009 1919 1930
28. N.A. Kasim, M. Whitehouse, C. Ramachandran, M. Bermejo, H. Lennernäs, A.S. Hussain, H.E. Junginger, S.A. Stavchansky, K.K. Midha, V.P. Shah, and G.L. Amidon Molecular properties of WHO essential drugs and provisional biopharmaceutical classification Molecular Pharmaceutics 1 2004 85 96
29. H. Lennernäs Human intestinal permeability Journal of Pharmaceutical Scinces 87 1998 403 410 (Pubitemid 28175799)
30. H. Lennernäs Intestinal permeability and its relevance for absorption and elimination Xenobiotica 37 2007 1015 1051 (Pubitemid 350035536)
31. Lennernäs, H., 2013. Regional intestinal drug permeation: Biopharmaceutics and drug development. European Journal of Pharmaceutical Sciences 57, 333-341.
32. M. Lindenberg, S. Kopp, and J.B. Dressman Classification of orally administered drugs on the World Health Organization model list of essential medicines according to the biopharmaceutics classification system European Journal of Pharmaceutics and Biopharmaceutics 58 2004 265 278 (Pubitemid 39037234)
33. R. Lobenberg, and G.L. Amidon Modern bioavailability, bioequivalence and biopharmaceutics classification system. New scientific approaches to international regulatory standards European Journal of Pharmaceutics and Biopharmaceutics 50 2000 3 12 (Pubitemid 30326685)
34. M.N. Martinez, and G.L. Amidon A mechanistic approach to understanding the factors affecting drug absorption: a review of fundamentals Journal of Clinical Pharmacology 42 2002 620 643 (Pubitemid 34547446)
35. W.M. Meylan, and P.H. Howard Atom/fragment contribution method for estimating octanol-water partition coefficients Journal of Pharmaceutical Sciences 84 1995 83 92 (Pubitemid 26066014)
36. J.M. Miller, A. Dahan, D. Gupta, S. Varghese, and G.L. Amidon Enabling the intestinal absorption of highly polar antiviral agents: Ion-pair facilitated membrane permeation of zanamivir heptyl ester and guanidino oseltamivir Molecular Pharmaceutics 7 2010 1223 1234
37. J.M. Miller, A. Beig, B.J. Krieg, R.A. Carr, T.B. Borchardt, G.E. Amidon, G.L. Amidon, and A. Dahan The solubility-permeability interplay: mechanistic modeling and predictive application of the impact of micellar solubilization on intestinal permeation Molecular Pharmaceutics 8 2011 1848 1856
38. J.M. Miller, A. Beig, R.A. Carr, J.K. Spence, and A. Dahan A win-win solution in oral delivery of lipophilic drugs: Supersaturation via amorphous solid dispersions increases apparent solubility without sacrifice of intestinal membrane permeability Molecular Pharmaceutics 9 2012 2009 2016
39. J.M. Miller, A. Beig, R.A. Carr, G.K. Webster, and A. Dahan The solubility-permeability interplay when using cosolvents for solubilization: revising the way we use solubility-enabling formulations Molecular Pharmaceutics 9 2012 581 590
40. F. Moolenaar, G. Grasmeijer, J. Visser, and D.K.F. Meijer Rectal versus oral absorption of codeine phosphate in man Biopharmaceutics & Drug Disposition 4 1983 195 199 (Pubitemid 13107554)
41. D.M. Mudie, G.L. Amidon, and G.E. Amidon Physiological parameters for oral delivery and in vitro testing Molecular Pharmaceutics 7 2010 1388 1405
42. J. Polli, B. Abrahamsson, L. Yu, G. Amidon, J. Baldoni, J. Cook, P. Fackler, K. Hartauer, G. Johnston, S. Krill, R. Lipper, W. Malick, V. Shah, D. Sun, H. Winkle, Y. Wu, and H. Zhang Summary workshop report: bioequivalence, biopharmaceutics classification system, and beyond The AAPS Journal 10 2008 373 379
43. H. Quiding, P. Anderson, U. Bondesson, L.O. Boréus, and P.Å. Hynning Plasma concentrations of codeine and its metabolite, morphine, after single and repeated oral administration European Journal of Clinical Pharmacology 30 1986 673 677 (Pubitemid 16018945)
44. E. Ramirez, O. Laosa, P. Guerra, B. Duque, B. Mosquera, A.M. Borobia, S.H. Lei, A.J. Carcas, and J. Frias Acceptability and characteristics of 124 human bioequivalence studies with active substances classified according to the biopharmaceutic classification system British Journal of Clinical Pharmacology 70 2010 694 702
45. Å. Sjöberg, M. Lutz, C. Tannergren, C. Wingolf, A. Borde, and A.-L. Ungell Comprehensive study on regional human intestinal permeability and prediction of fraction absorbed of drugs using the Ussing chamber technique European Journal of Pharmaceutical Sciences 48 2013 166 180
46. E. Sjögren, J. Westergren, I. Grant, G. Hanisch, L. Lindfors, H. Lennernäs, B. Abrahamsson, and C. Tannergren In silico predictions of gastrointestinal drug absorption in pharmaceutical product development: Application of the mechanistic absorption model GI-Sim European Journal of Pharmaceutical Sciences 49 2013 679 698
47. S. Skolnik, X. Lin, J. Wang, X.-H. Chen, T. He, and B. Zhang Towards prediction of in vivo intestinal absorption using a 96-well Caco-2 assay Journal of Pharmaceutical Sciences 99 2010 3246 3265
48. T. Takagi, C. Ramachandran, M. Bermejo, S. Yamashita, L.X. Yu, and G.L. Amidon A provisional biopharmaceutical classification of the top 200 oral drug products in the United States, Great Britain, Spain, and Japan Molecular Pharmaceutics 3 2006 631 643 (Pubitemid 46087480)
49. Z.S. Teksin, K. Hom, A. Balakrishnan, and J.E. Polli Ion pair-mediated transport of metoprolol across a three lipid-component PAMPA system Journal of Controlled Release 116 2006 50 57 (Pubitemid 44792301)
50. T.B. Vree, and C.P.W.G.M.V.-V. Wissen Pharmacokinetics and metabolism of codeine in humans Biopharmaceutics & Drug Disposition 13 1992 445 460
51. J.G. Wagner, and A.J. Sedman Quantitaton of rate of gastrointestinal and buccal absorption of acidic and basic drugs based on extraction theory Journal of Pharmacokinetics and Pharmacodynnamics 1 1973 23 50
52. S. Winiwarter, N.M. Bonham, F. Ax, A. Hallberg, H. Lennernäs, and A. Karlén Correlation of human jejunal permeability (in vivo) of drugs with experimentally and theoretically derived parameters. A multivariate data analysis approach Journal of Medicinal Chemistry 41 1998 4939 4949 (Pubitemid 28555452)
53. D. Winne Shift of pH-absorption curves Journal of Pharmacokinetics and Biopharmaceutics 5 1977 53 94
54. F. Wohnsland, and B. Faller High-throughput permeability pH profile and high-throughput alkane/water Log P with artificial membranes Journal of Medicinal Chemistry 44 2001 923 930 (Pubitemid 32861617)
55. C.-Y. Wu, and L.Z. Benet Predicting drug disposition via application of BCS: transport/absorption/elimination interplay and development of a biopharmaceutics drug disposition classification system Pharmaceutical Research 22 2005 11 23 (Pubitemid 40558141)
56. S.H. Yalkowsky, J.L.H. Johnson, T. Sanghvi, and S.G. Machatha A 'rule of unity' for human intestinal absorption Pharmaceutical Research 23 2006 2475 2481 (Pubitemid 44511526)
57. L.X. Yu, G.L. Amidon, J.E. Polli, H. Zhao, M.U. Mehta, D.P. Conner, V.P. Shah, L.J. Lesko, M.L. Chen, V.H.L. Lee, and A.S. Hussain Biopharmaceutics classification system: the scientific basis for biowaiver extensions Pharmaceutical Research 19 2002 921
58. Y.H. Zhao, J. Le, M.H. Abraham, A. Hersey, P.J. Eddershaw, C.N. Luscombe, D. Boutina, G. Beck, B. Sherborne, I. Cooper, and J.A. Platts Evaluation of human intestinal absorption data and subsequent derivation of a quantitative structure-activity relationship (QSAR) with the Abraham descriptors Journal of Pharmaceutical Sciences 90 2001 749 784 (Pubitemid 32530451)